Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

BVMF/ONCO3 stock hub

BVMF/ONCO3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/ONCO3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/ONCO3

In the news

Latest news · BVMF/ONCO3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-165.2

P25 n/aP50 n/aP75 n/a

ROIC-27.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/ONCO3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

BRL

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Brazil
Country code	BR
Enterprise value	BRL 4.9B
Exchange	Brazil Stock Exchange
Financial currency	BRL
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	BRONCOACNOR6
Last refreshed	2026-05-10
Market cap	BRL 1.4B
Price	BRL 1.26
Price currency	BRL
Sector	Healthcare
Sic	8011
Symbol	bvmf/ONCO3
Website	https://grupooncoclinicas.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-257.2%
EV Earnings	-1.36x
EV/FCF	-17.13x
EV/Sales	0.86x
FCF yield	-20.35%
Forward P/E	9x
P/B ratio	1.33x
P/S ratio	0.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-23.79%
EBITDA Margin	-20.77%
Gross margin	31.12%
Gross Profit	BRL 1.8B
Gross Profit Growth	-13.3%
Gross Profit Growth Q	-4.41%
Gross Profit Growth3 Y	7.15%
Gross Profit Growth5 Y	22.95%
Net Income	BRL -3.6B
Net Income Growth Years	0%
Pretax Margin	-55.1%
Profit Margin	-63.14%
ROA	-9.31
Roa5y	1.38
ROCE	-70.79
ROE	-165.2
Roe5y	-34.8
ROIC	-27.14
Roic5y	1.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-75.87%
Cagr3y	-47.82%
EPS Growth Years	0
OCF Growth Q	689.29%
Revenue Growth	-7.83x
Revenue Growth Q	-12.59x
Revenue Growth Years	0x
Revenue Growth3 Y	11.97x
Revenue Growth5 Y	23.04x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.63
Assets	BRL 7.1B
Cash	BRL 512.7M
Current Assets	BRL 2.9B
Current Liabilities	BRL 5.2B
Debt	BRL 3.9B
Debt Equity	BRL 3.63
Debt FCF	BRL -13.44
Equity	BRL 1.1B
Interest Coverage	-2.11
Liabilities	BRL 6.1B
Long Term Assets	BRL 4.2B
Long Term Liabilities	BRL 866.2M
Net Cash	BRL -3.3B
Net Cash By Market Cap	BRL -237
Net Debt Equity	BRL 3.15
Tangible Book Value	BRL -1.8B
Tangible Book Value Per Share	BRL -1.59
WACC	12.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.56
Inventory Turnover	19.25
Net Working Capital	BRL 461.6M
Quick ratio	0.43
Working Capital	BRL -2.3B
Working Capital Turnover	BRL -117

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-40.59%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-75.84%
200-day SMA	2.65
3Y total return	-85.8%
50-day SMA	1.74
50-day SMA vs 200-day SMA	50under200
All Time High	19.62
All Time High Change	-93.58%
All Time High Date	2021-08-10
All Time Low	1.09
All Time Low Change	15.6%
All Time Low Date	2026-04-14
ATR	0.2
Beta	1.02
Beta1y	0.85
Beta2y	1.19
Ch YTD	-53.51
High	1.5
High52	6
High52 Date	2025-07-30
High52ch	-79%
Low	1.24
Low52	1.09
Low52 Date	2026-04-14
Low52ch	15.6%
Ma50ch	-27.63%
Price vs 200-day SMA	-52.49%
RSI	38.25
RSI Monthly	35.94
RSI Weekly	36
Sharpe ratio	-0.67x
Sortino ratio	-0.97
Total Return	-40.59%
Tr YTD	-53.51
Tr1m	-20.25%
Tr1w	-18.71%
Tr3m	-49.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL -1.4B
Operating margin	-23.79

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	447,222,171%
Net Borrowing	-468,389,000
Shares Insiders	5.08%
Shares Institutions	53.8%
Shares Out	1,118,202,391
Shares Qo Q	134.3%
Shares Yo Y	40.59%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL -308.9M
Average Volume	8,530,905x
Bv Per Share	0.81
CAPEX	BRL -168.1M
Ch1m	-20.25
Ch1w	-18.71
Ch1y	-76.75
Ch3m	-49.4
Ch3y	-86.33
Ch6m	-30.77
Change	-13.7%
Change From Open	-15.44
Close	1.46
Days Gap	2.05
Depreciation Amortization	173,370,000
Dollar Volume	9,224,082
Earnings Date	2026-05-14
EBIT	BRL -1.4B
EBITDA	BRL -1.2B
EPS	BRL -4.18
F Score	3
FCF	BRL -286.7M
FCF EV Yield	-5.84x
FCF Per Share	BRL -0.26
Financing CF	-717,782,000
Fiscal Year End	December
Founded	2,010
Goodwill	1,438,830,000
Income Tax	BRL 508.5M
Investing CF	793,030,000
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Ma150	2.17
Ma150ch	-41.99%
Ma20	1.51
Ma20ch	-16.39%
Net CF	-41,195,000
Next Earnings Date	2026-05-14
Open	1.49
Position In Range	7.69
Ppne	1,102,606,000
Price Date	2026-05-08
Relative Volume	0.83x
Revenue	5,739,367,000x
SBC By Revenue	0.39x
Share Based Comp	22,182,000
Tax By Revenue	8.86x
Tr6m	-30.77%
Volume	7,320,700
Z Score	-0.8

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BVMF/ONCO3 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/ONCO3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/ONCO3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+53.8%

Share of float held by funds and institutions

Insider ownership

+5.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+40.6%

Negative means the company is buying back shares.

Technical

BVMF/ONCO3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.2

Neutral momentum band

Price vs 200-day MA

-52.5%

50/200-day relationship not available

Beta (5Y)

1.02

Moves roughly with the market

Sharpe ratio

-0.67

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/ONCO3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/ONCO3 stock rating?

bvmf/ONCO3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/ONCO3 analysis?

The full report lives at /stocks/bvmf/ONCO3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/ONCO3?

The latest report frames bvmf/ONCO3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/ONCO3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.